Home/Filings/4/0001179110-18-008523
4//SEC Filing

Paull Robert Bradley 4

Accession 0001179110-18-008523

CIK 0001479419other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:46 PM ET

Size

5.3 KB

Accession

0001179110-18-008523

Insider Transaction Report

Form 4
Period: 2018-06-12
Paull Robert Bradley
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2018-06-12+12,96012,960 total
    Exercise: $13.73Exp: 2028-06-11Common Stock (12,960 underlying)
Footnotes (1)
  • [F1]This option was granted on June 12, 2018 and vests in equal monthly installments until the one-year anniversary of the date of grant and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Issuer

Kala Pharmaceuticals, Inc.

CIK 0001479419

Entity typeother

Related Parties

1
  • filerCIK 0001711254

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:46 PM ET
Size
5.3 KB